GILEAD SCIENCES, INC.
GILD · Nasdaq · CIK 0000882095
SIC 2836
Biological Products, (No Diagnostic Substances)
Category
Chemicals
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
ROE
37.48%
ROA
14.42%
Current Ratio
1.55
Gross Margin
24.02%
Operating Margin
40.59%
Net Margin
34.47%
Book Value/Share
$18.29
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-24
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of Revenue | 6,234 | 6,251 | 6,498 | 5,657 | 6,601 |
| Operating Income | 10,022 | 1,662 | 7,605 | 7,330 | 9,918 |
| Net Income | 8,510 | 480 | 5,665 | 4,592 | 6,225 |
| EPS (Basic) | 6.84 | 0.38 | 4.54 | 3.66 | 4.96 |
| EPS (Diluted) | 6.78 | 0.38 | 4.50 | 3.64 | 4.93 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
| Current Assets | 18,342 | 19,173 | 16,085 | 14,443 | 14,772 |
| Cash & Equivalents | — | — | — | 5,412 | 5,338 |
| Current Liabilities | 11,813 | 12,004 | 11,280 | 11,237 | 11,610 |
| Long-term Debt | 24,937 | 26,710 | 24,987 | 25,229 | 26,695 |
| Total Equity | 22,703 | 19,330 | 22,833 | 21,240 | 21,069 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 10,019 | 10,828 | 8,006 | 9,072 | 11,384 |
| Investing CF | -4,793 | -3,449 | -2,265 | -2,466 | -3,131 |
| Financing CF | -7,745 | -3,433 | -5,125 | -6,469 | -8,877 |
| CapEx | 563 | 523 | 585 | 728 | 579 |
| Dividends Paid | 4,003 | 3,918 | 3,809 | 3,709 | 3,605 |
📄 SEC Filings
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2026-05-08
Open →
Quarterly Report
FORM 10-Q
2026-05-07
Open →
Current Report
FORM 8-K
2026-05-07
Open →
Current Report
FORM 8-K
2026-05-04
Open →
Current Report
FORM 8-K
2026-04-28
Open →
Proxy Statement
DEFINITIVE PROXY STATEMENT
2026-03-20
Open →
Annual Report
FORM 10-K
2026-02-24
Open →
Current Report
FORM 8-K
2026-02-23
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2026-02-12
Open →
Current Report
FORM 8-K
2026-02-10
Open →
Current Report
FORM 8-K
2025-11-19
Open →
Other filings (89)
FWP
FWP
2026-05-14
Open →
424B5
424B5
2026-05-14
Open →
S-8
FORM S-8
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
144
xsl144X01/primary_doc.xml
2026-04-28
Open →
SCHEDULE 13D/A
xslSCHEDULE_13D_X02/primary_doc.xml
2026-04-28
Open →
SC TO-T/A
SC TO-T/A
2026-04-28
Open →
SC TO-T/A
SC TO-T/A
2026-04-17
Open →
Insider Transaction
FORM 4
2026-04-16
Open →
Insider Transaction
FORM 4
2026-04-16
Open →
144
xsl144X01/primary_doc.xml
2026-04-15
Open →
144
xsl144X01/primary_doc.xml
2026-04-15
Open →
SC TO-T/A
SC TO-T/A
2026-04-01
Open →
Insider Transaction
FORM 4
2026-03-30
Open →
144
xsl144X01/primary_doc.xml
2026-03-27
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-26
Open →
ARS
ANNUAL REPORT TO SECURITY HOLDERS
2026-03-20
Open →
DEFA14A
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-17
Open →
Insider Transaction
FORM 4
2026-03-17
Open →
144
xsl144X01/primary_doc.xml
2026-03-16
Open →
144
xsl144X01/primary_doc.xml
2026-03-16
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
SC TO-T
SC TO-T
2026-03-06
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
144
xsl144X01/primary_doc.xml
2026-02-27
Open →
SC TO-C
SC TO-C
2026-02-23
Open →
SCHEDULE 13D
xslSCHEDULE_13D_X01/primary_doc.xml
2026-02-23
Open →
SC TO-C
SC TO-C
2026-02-23
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
3
FORM 3
2026-02-12
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-02-12
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-02-12
Open →
Insider Transaction
FORM 4
2026-02-06
Open →
Insider Transaction
FORM 4
2026-02-05
Open →
Insider Transaction
FORM 4
2026-02-05
Open →
Insider Transaction
FORM 4
2026-02-05
Open →
144
xsl144X01/primary_doc.xml
2026-02-05
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X01/primary_doc.xml
2026-02-05
Open →
Insider Transaction
FORM 4
2026-01-29
Open →
144
xsl144X01/primary_doc.xml
2026-01-28
Open →
Insider Transaction
FORM 4
2026-01-26
Open →
144
xsl144X01/primary_doc.xml
2026-01-23
Open →
144
xsl144X01/primary_doc.xml
2026-01-22
Open →
Insider Transaction
FORM 4
2026-01-21
Open →
144
xsl144X01/primary_doc.xml
2026-01-20
Open →
Insider Transaction
FORM 4
2026-01-16
Open →
Insider Transaction
FORM 4
2026-01-16
Open →
144
xsl144X01/primary_doc.xml
2026-01-15
Open →
144
xsl144X01/primary_doc.xml
2026-01-15
Open →
Insider Transaction
FORM 4
2026-01-05
Open →
Insider Transaction
FORM 4
2025-12-30
Open →
144
xsl144X01/primary_doc.xml
2025-12-29
Open →
Insider Transaction
FORM 4
2025-12-16
Open →
Insider Transaction
FORM 4
2025-12-16
Open →
144
xsl144X01/primary_doc.xml
2025-12-15
Open →
144
xsl144X01/primary_doc.xml
2025-12-15
Open →
Insider Transaction
FORM 4
2025-12-11
Open →
Insider Transaction
FORM 4
2025-12-11
Open →
Insider Transaction
FORM 4
2025-12-11
Open →
Insider Transaction
FORM 4
2025-12-01
Open →
Insider Transaction
FORM 4
2025-12-01
Open →
Insider Transaction
FORM 4
2025-12-01
Open →
Insider Transaction
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2025-12-01
Open →
144
xsl144X01/primary_doc.xml
2025-11-28
Open →
144
xsl144X01/primary_doc.xml
2025-11-28
Open →
144
xsl144X01/primary_doc.xml
2025-11-26
Open →